CARBA-5
LIVE

Serial Number

79424023

Owner

NG Biotech

Attorney

Jeffrey H. Handelsman

Filing Date

Mar 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CARBA-5 Trademark

Serial Number: 79424023 • Registration: 8299691

CARBA-5 is a trademark filed by NG Biotech on March 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

NG Biotech

Atelier Relais Le Tremplin, Parc d'act. de Courbou

Entity Type: 99

Trademark Details

Filing Date

March 25, 2025

Registration Date

June 16, 2026

Published for Opposition

April 28, 2026

Goods & Services

Apparatus for conducting diagnostic tests for medical use, namely, medical diagnostic apparatus for testing body fluids, bacterial cultures, bacterial colonies and blood culture samples; instruments for carrying out medical diagnostic tests, namely, medical diagnostic apparatus for testing biological samples for the qualitative detection and differentiation of expressed antibiotic resistance mechanisms in drug-resistant bacteria; apparatus and instruments for carrying out qualitative medical diagnostic tests based on lateral-flow Immunoassay, namely, medical diagnostic apparatus for testing biological samples for the rapid detection and differentiation of carbapenemases; medical apparatus for reading analytical tests, namely, medical diagnostic apparatus for testing biological samples, bacterial cultures and blood culture samples for the detection of carbapenemase resistance; testing instruments for medical diagnostic use, namely, medical diagnostic apparatus for testing bacterial colonies for the detection and differentiation of the most common carbapenemase families

Medical diagnostic tests, namely, medical diagnostic reagents and assays for testing of body fluids, bacterial cultures, bacterial colonies and blood culture samples; immunochromatographic tests for medical diagnosis, namely, medical diagnostic test strips for the analysis of body fluids, bacterial cultures, bacterial colonies and blood culture samples; qualitative medical diagnostic tests based on lateral-flow Immunoassay, namely, immunoassay reagents for medical use; reagents for medical diagnostic tests; strips for medical diagnostic tests, namely, medical diagnostic test strips for use in the field of qualitative detection and differentiation of expressed antibiotic resistance mechanisms in drug-resistant bacteria; medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing of body fluids, bacterial cultures, bacterial colonies and blood culture samples for use in disease detection, namely, for the rapid detection and differentiation of carbapenemases

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 16, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 28, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 28, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2026 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 20, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2026 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 19, 2026 NREP
REFUSAL PROCESSED BY IB
Oct 31, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 16, 2025 RFCS
REFUSAL PROCESSED BY MPU
Oct 16, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 22, 2025 REPR